These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

348 related articles for article (PubMed ID: 27273843)

  • 21. Study protocol for an efficacy trial of the "PrEP for Health" intervention to increase HIV PrEP use among people who inject drugs.
    Bazzi AR; Bordeu M; Baumgartner K; Sproesser DM; Bositis CM; Krakower DS; Mimiaga MJ; Biello KB
    BMC Public Health; 2023 Mar; 23(1):513. PubMed ID: 36932369
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Contingency Management and Pre-Exposure Prophylaxis Adherence Support Services (CoMPASS): A hybrid type 1 effectiveness-implementation study to promote HIV risk reduction among people who inject drugs.
    Sung ML; Viera A; Esserman D; Tong G; Davidson D; Aiudi S; Bailey GL; Buchanan AL; Buchelli M; Jenkins M; John B; Kolakowski J; Lame A; Murphy SM; Porter E; Simone L; Paris M; Rash CJ; Edelman EJ
    Contemp Clin Trials; 2023 Feb; 125():107037. PubMed ID: 36460267
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Living at the Confluence of Stigmas: PrEP Awareness and Feasibility Among People Who Inject Drugs in Two Predominantly Rural States.
    Carter G; Meyerson B; Rivers P; Crosby R; Lawrence C; Cope SD; DeBruicker D; Levin S; Meeks W; Thomas C; Turner B; Abert C; Coles H; Allen A; Gonzalez-Fagoaga E; Grivois-Shah R
    AIDS Behav; 2021 Oct; 25(10):3085-3096. PubMed ID: 34003385
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Low PrEP Awareness and Use Among People Who Inject Drugs, San Francisco, 2018.
    McFarland W; Lin J; Santos GM; Arayasirikul S; Raymond HF; Wilson E
    AIDS Behav; 2020 May; 24(5):1290-1293. PubMed ID: 31563984
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A missing perspective: injectable pre-exposure prophylaxis for people who inject drugs.
    Biello KB; Edeza A; Salhaney P; Biancarelli DL; Mimiaga MJ; Drainoni ML; Childs ES; Bazzi AR
    AIDS Care; 2019 Oct; 31(10):1214-1220. PubMed ID: 30822103
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Awareness of and interest in oral pre-exposure prophylaxis (PrEP) for HIV prevention and interest in hypothetical forms of PrEP among people who inject drugs in rural West Virginia.
    Schneider KE; White RH; O'Rourke A; Kilkenny ME; Perdue M; Sherman SG; Grieb SM; Allen ST
    AIDS Care; 2021 Jun; 33(6):721-728. PubMed ID: 32951438
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Acceptability of HIV Pre-exposure Prophylaxis (PREP) Among People Who Inject Drugs (PWID) in a Canadian Setting.
    Escudero DJ; Kerr T; Wood E; Nguyen P; Lurie MN; Sued O; Marshall BD
    AIDS Behav; 2015 May; 19(5):752-7. PubMed ID: 25086669
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Acceptability of injectable pre-exposure prophylaxis among people who inject drugs in three urban U.S. settings.
    King AR; Shah S; Randall LA; Frew PM; Spaulding A; ; Holloway IW
    BMC Infect Dis; 2022 Sep; 22(1):737. PubMed ID: 36104676
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Patient and Provider Perspectives on a Novel, Low-Threshold HIV PrEP Program for People Who Inject Drugs Experiencing Homelessness.
    Bazzi AR; Shaw LC; Biello KB; Vahey S; Brody JK
    J Gen Intern Med; 2023 Mar; 38(4):913-921. PubMed ID: 35614171
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Provider Implicit Bias in Prescribing HIV Pre-exposure Prophylaxis (PrEP) to People Who Inject Drugs.
    Dubov A; Krakower DS; Rockwood N; Montgomery S; Shoptaw S
    J Gen Intern Med; 2023 Oct; 38(13):2928-2935. PubMed ID: 36964426
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Some PWID communities are ready for PrEP, so what's next?
    Bruneau J; Roy É; Demers N; Cox J
    Addiction; 2017 Apr; 112(4):582-584. PubMed ID: 27995679
    [No Abstract]   [Full Text] [Related]  

  • 32. Real-World Eligibility for HIV Pre-exposure Prophylaxis Among People Who Inject Drugs.
    Picard J; Jacka B; Høj S; Laverdière É; Cox J; Roy É; Bruneau J
    AIDS Behav; 2020 Aug; 24(8):2400-2408. PubMed ID: 31997057
    [TBL] [Abstract][Full Text] [Related]  

  • 33. HIV pre-exposure prophylaxis for people who inject drugs: a review of current results and an agenda for future research.
    Escudero DJ; Lurie MN; Kerr T; Howe CJ; Marshall BD
    J Int AIDS Soc; 2014; 17(1):18899. PubMed ID: 24679634
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long-Acting Injectable Human Immunodeficiency Virus Pre-Exposure Prophylaxis Preferred Over Other Modalities Among People Who Inject Drugs: Findings from a Qualitative Study in California.
    Bazzi AR; Valasek CJ; Streuli SA; Vera CF; Harvey-Vera A; Philbin MM; Biello KB; Roth AM; Strathdee SA; Pines HA
    AIDS Patient Care STDS; 2022 Jul; 36(7):254-262. PubMed ID: 35727647
    [TBL] [Abstract][Full Text] [Related]  

  • 35. PrEP Care Continuum Engagement Among Persons Who Inject Drugs: Rural and Urban Differences in Stigma and Social Infrastructure.
    Walters SM; Frank D; Van Ham B; Jaiswal J; Muncan B; Earnshaw V; Schneider J; Friedman SR; Ompad DC
    AIDS Behav; 2022 Apr; 26(4):1308-1320. PubMed ID: 34626265
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Perceptions of people who inject drugs towards HIV pre-exposure prophylaxis in Australia.
    Read P; Chronister KJ; Kostovski C; Harrod ME; Salmon A; Jauncey M
    Sex Health; 2019 Aug; 16(4):383-388. PubMed ID: 31203837
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expanding Access to Oral Preexposure Prophylaxis for People Who Inject Drugs in Bayelsa and Niger States, Nigeria.
    Nishimoto L; Ikani P; Achanya J; Idowu A; Olisa AL; Walker CF; Gottlieb A; Akolo C
    Glob Health Sci Pract; 2023 Feb; 11(1):. PubMed ID: 36853631
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A Capacity-Strengthening Intervention to Support HIV Pre-exposure Prophylaxis (PrEP) Awareness-Building and Promotion by Frontline Harm Reduction Workers in Baltimore, Maryland: A Mixed Methods Evaluation.
    Rosen JG; Zhang L; Pelaez D; Park JN; Glick JL
    AIDS Behav; 2023 Jul; 27(7):2440-2453. PubMed ID: 36596866
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Vital Signs: Estimated Percentages and Numbers of Adults with Indications for Preexposure Prophylaxis to Prevent HIV Acquisition--United States, 2015.
    Smith DK; Van Handel M; Wolitski RJ; Stryker JE; Hall HI; Prejean J; Koenig LJ; Valleroy LA
    MMWR Morb Mortal Wkly Rep; 2015 Nov; 64(46):1291-5. PubMed ID: 26606148
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Factors Associated with Awareness of Pre-exposure Prophylaxis for HIV Among Persons Who Inject Drugs in Philadelphia: National HIV Behavioral Surveillance, 2015.
    Roth A; Tran N; Piecara B; Welles S; Shinefeld J; Brady K
    AIDS Behav; 2019 Jul; 23(7):1833-1840. PubMed ID: 30267367
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.